IL-1ra and CCL5, but not IL-10, are promising targets for treating SMA astrocyte-driven pathology

Reilly L. Allison(Medical College of Wisconsin), Allison D. Ebert(Medical College of Wisconsin)
Molecular Therapy
December 12, 2024
Cited by 3


Related Papers